Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
biotech
fda
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abbvie
acorda therapeutics
aimmune therapeutics
akcea therapeutics
allergy
alnylam pharmaceuticals
ampyra
anaphylaxis
andrew oxtoby
apokyn
apomorphine
barry greene
boston
boston university
boulder/denver blog main
boulder/denver top stories
dalfampridine
dan ollendorf
daniel edelman
detroit blog main
detroit top stories
drugs
duopa
eosinophilic esophagitis
food allergy
hereditary transthyretin amyloidosis
What
fda
friday
3
×
approved
drug
late
patients
time
acorda
agency
ago
aimmune
allergy
alnylam
approval
approve
awaits
awarded
biological
cope
crossed
decades
decision
developed
discovered
disease
episodes
fingers
gets
help
historic
immunotherapy
looms
meant
medications
medicine
new
nod
oral
parkinson’s
peanut
Language
unset
Current search:
friday
×
" new york blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision